Alnylam Pharmaceuticals
The Translational Research Team at Alnylam is seeking a Proteomics Scientist to advance RNAi therapeutics through preclinical target validation, biomarker discovery, and innovation of novel delivery solutions. The role involves developing state-of-the-art workflows in spatial, single-cell, and subcellular proteomics using LC/MS-based technologies and collaborating with an interdisciplinary team to identify novel receptors for targeted delivery. The position is based onsite in Cambridge, MA.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alnylam Pharmaceuticals.
Alnylam Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
66% above the average for this role